Back to Trials
NCT06259097PHASE3Recruiting

Different Medications to Induce Labor

Icahn School of Medicine at Mount Sinai

Start Date

7/2/2024

Completion Date

8/1/2026

Summary

This is a randomized controlled trial examining whether the use of misoprostol or pitocin, in combination with a foley catheter, is more effective at inducing labor in patients with a gravid BMI that is considered obese.

Detailed Description

This randomized controlled trial will include patients with a BMI greater than 30 at the time of admission for their induction of labor. Patients will be randomized to either misoprostol or Pitocin to begin induction of labor, alongside the standard foley catheter, and the primary outcome of interest will be length of time from start of induction until delivery.

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion Criteria: \- Pregnant patient presenting to labor \& delivery for induction of labor with a BMI \> = 30 Exclusion Criteria: \- Pregnant patient presenting to labor \& delivery for induction of labor with BMI \< 30

Interventions

DRUG

Misoprostol

DRUG

Pitocin

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

PregnancyLabor

Locations

Mount Sinai Hospital

New York, New York 10029

United States

Bronx Care Health System

The Bronx, New York 10457

United States